论文部分内容阅读
目的:探讨门冬氨酸钾镁联合银杏叶提取物对慢性充血性心力衰竭的临床疗效。方法:将158例慢性充血性心力衰竭患者随机分为治疗组和对照组,两组均采用常规强心、利尿、血管扩张药、ACEI类或ARB 类药物等治疗。治疗组在常规治疗基础上再用门冬氨酸钾镁联合银杏叶提取物;两组进行对照观察。结果: 治疗组临床疗效和左室射血分数(LVEF)与对照组比较差异有显著性意义(P<0．05)。结论:门冬氨酸钾镁联合银杏叶提取物治疗慢性充血性心力衰竭有良好疗效。且无明显毒副作用。
Objective: To investigate the clinical efficacy of potassium aspartate, magnesium and ginkgo biloba extract on chronic congestive heart failure. Methods: 158 patients with chronic congestive heart failure were randomly divided into treatment group and control group. Both groups were treated with conventional cardioplegia, diuretic, vasodilator, ACEI or ARB. The treatment group on the basis of conventional treatment with potassium aspartate magnesium Ginkgo biloba extract; control two groups were observed. Results: The clinical efficacy and left ventricular ejection fraction (LVEF) in the treatment group were significantly different from those in the control group (P <0.05). Conclusion: Aspartate, potassium and magnesium combined with Ginkgo biloba extract has a good curative effect on chronic congestive heart failure. And no obvious side effects.